Jim Reddoch is a highly accomplished individual with a diverse educational and professional background. He attained his High School Diploma from Mountain Brook HS and later acquired his BA in Political Science from Furman University. He continued his education with a PhD in Biochemistry from the University of Alabama at Birmingham before pursuing a Postdoc in Genetics at Yale University.

Reddoch has worked in several organizations in the science and technology industry. He currently serves as the Chief Scientific Officer and EVP of Research & Investments at Royalty Pharma. He has also held positions as Managing Director & Head of Healthcare Research at FBR Capital Markets, Senior Vice President Biotech Analyst at Banc of America Securities, Equity Research Associate (Biotech) at CIBC World Markets, and Board Member at Avillion. Additionally, he previously served as a member of the External Review Committee for Technology Development Fund at Memorial Sloan Kettering Cancer Center.

With his extensive experience in biotech research, Reddoch is a leading expert on various topics in the healthcare and sciences industry. Notable interests include technology development and investments in healthcare.